Literature DB >> 17882401

Molecular cloning and functional expression of the murine noradrenaline transporter.

Andrea Muck1, Ralf Gilsbach, Sandra Löbbe-Werner, Michael Brüss, Heinz Bönisch.   

Abstract

The cDNA of the murine noradrenaline transporter (mNAT) was cloned from the RNA of the placenta of a C57BL/6 mouse. The cloned mNAT differs from a previously published sequence in two amino acids within the C-terminal region. A cDNA obtained from an inbred mouse strain showed a further amino acid exchange (Ile(505)Val) within the fifth intracellular loop. The pharmacological properties of both, the wild-type mNAT and the variant (mNAT-I(505)V), were studied in human embryonic kidney HEK293 cells transfected with the corresponding cDNA. The kinetic constants for transport (K (m), V (max)) of [(3)H]noradrenaline ([(3)H]-NA) and binding (K (D), B (max)) of the selective NAT inhibitor [(3)H]nisoxetine were not different between the two isoforms; the mean kinetic constants amounted to about 4 microM and 120pmol/mg protein for K (m) and V (max) and 6nM and 18pmol/mg protein for K (D) and B (max), respectively. [(3)H]-NA transport by both isoforms showed the typical properties of an NAT because it was dependent on sodium and chloride and inhibited with almost identical K (i) values by various NAT substrates and inhibitors. The only significant pharmacological difference identified between the two mNAT isoforms was an about threefold higher affinity for cocaine of the very rare mNAT-I(505)V variant.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17882401     DOI: 10.1007/s00210-007-0181-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

Review 1.  Three-dimensional models of neurotransmitter transporters and their interactions with cocaine and S-citalopram.

Authors:  Aina Westrheim Ravna
Journal:  World J Biol Psychiatry       Date:  2006       Impact factor: 4.132

2.  Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screening.

Authors:  G Stöber; J Hebebrand; S Cichon; M Brüss; H Bönisch; G Lehmkuhl; F Poustka; M Schmidt; H Remschmidt; P Propping; M M Nöthen
Journal:  Am J Med Genet       Date:  1999-04-16

Review 3.  Neurotransmitter transporters: molecular biology, function, and regulation.

Authors:  B Borowsky; B J Hoffman
Journal:  Int Rev Neurobiol       Date:  1995       Impact factor: 3.230

Review 4.  The noradrenaline transporter of the neuronal plasma membrane.

Authors:  H Bönisch; M Brüss
Journal:  Ann N Y Acad Sci       Date:  1994-09-15       Impact factor: 5.691

5.  Pharmacological properties of naturally occurring variants of the human norepinephrine transporter.

Authors:  F Runkel; M Brüss; M M Nöthen; G Stöber; P Propping; H Bönisch
Journal:  Pharmacogenetics       Date:  2000-07

6.  Unexpected localization of the Na+/Cl--dependent-like orphan transporter, Rxt1, on synaptic vesicles in the rat central nervous system.

Authors:  J Masson; M Riad; F Chaudhry; M Darmon; Z Aïdouni; M Conrath; B Giros; M Hamon; J Storm-Mathisen; L Descarries; S El Mestikawy
Journal:  Eur J Neurosci       Date:  1999-04       Impact factor: 3.386

7.  Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters.

Authors:  F A Paczkowski; L J Bryan-Lluka; P Pörzgen; M Brüss; H Bönisch
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

8.  Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension.

Authors:  M S Rumantir; D M Kaye; G L Jennings; M Vaz; J A Hastings; M D Esler
Journal:  Hypertension       Date:  2000-11       Impact factor: 10.190

9.  Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders.

Authors:  G Stöber; M M Nöthen; P Pörzgen; M Brüss; H Bönisch; M Knapp; H Beckmann; P Propping
Journal:  Am J Med Genet       Date:  1996-11-22

10.  A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.

Authors:  Maureen K Hahn; David Robertson; Randy D Blakely
Journal:  J Neurosci       Date:  2003-06-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.